Understanding Repugnance: Implications for Public Policy

AuthorNicola Lacetera,Julio J. Elias,Mario Macis
Published date01 December 2017
DOIhttp://doi.org/10.1002/wmh3.246
Date01 December 2017
Understanding Repugnance: Implications for Public
Policy
Julio J. Elias , Nicola Lacetera, and Mario Macis
Understanding the inf‌luence of moral repugnance on social decisions is challenging, particularly
because in several cases not all of the relevant policy options can be observed. In a series of recent
studies, we designed survey experiments to identify individual preferences in morally controversial
transactions, with focus on the provision of payments to kidney donors in the United States (Elias,
Lacetera, & Macis, 2015a, 2015b, 2016a). We found that providing information on how a price
mechanism can help alleviate the organ shortage signif‌icantly reduces opposition toward payments
for organs. Moreover, we quantif‌ied the trade-off that people make between the repugnance and the
eff‌iciency of alternative kidney procurement systems. In Elias, Lacetera, Macis, and Salardi (2017),
f‌inally, we analyzed how the regulation of controversial activities is related to economic
development. This paper summarizes these f‌indings and analyzes their main implications for public
policy and market design.
KEY WORDS: repugnance, market for organs, economics and moral
Introduction
In most modern societies, several transactions are prohibited or restricted. In
addition to reasons related to health, safety, or negative externalities, the
motivation for banning certain trades resides mainly in ethical concerns—in other
words, societies perceive these transactions as “repugnant.” Roth (2007) intro-
duced in the economics literature the concept of “repugnance” for a transaction
as the aversion toward other individuals engaging in it, even if the parties
directly involved benef‌it from that trade (i.e., “There are some things no one
should be allowed to do”). Repugnance considerations have important conse-
quences on the types of markets and transactions that we observe and, as such,
they impose a challenge for policy and market design. This paper discusses recent
experimental evidence on repugnance and its main implications, with specif‌ic
reference to the procurement and allocation of kidneys for transplantation.
The United States as well as several other countries allow some forms of
“trades” in the kidney market, specif‌ically in the form of “kidney exchanges,”
World Medical & Health Policy, Vol. 9, No. 4, 2017
489
doi: 10.1002/wmh3.246
#2017 Policy Studies Organization
whereby pairs of living would-be donors and recipients who prove incompatible
look for another pair or pairs of donors and recipients who would be compatible
for transplants, cutting their wait time. However, monetary compensation to
people who give their organs are prohibited everywhere (with the exception of
the Islamic Republic of Iran), because this is considered morally unacceptable.
The current policy debate on using markets to boost donations relies mainly on
ethical arguments. One set of objections is based on concerns of exploitation of the
poor and coercion of choice. In a recent debate in the New York Times, ethicist
Katrina Bramstedt argues that allowing kidney sales would create “an economic
class war.” Another set of objections concerns the concept of human dignity that
payments would hamper (Gillespie, 2017); scholars have appealed to “inalienable
values” and “fundamental truths” in opposing payments, (Delmonico et al., 2002),
arguing that they would be “degrading the human condition” (Sandel, 2012). The
def‌initive words often used suggest that keeping these transactions out of the
marketplace is considered a “protected value”—that is, a value that people are
unwilling to trade off no matter what the costs of doing so may be. In fact,
arguments against payments for organs often acknowledge the potential benef‌its of
allowing such trades; yet the moral basis of the opposition is considered strong
enough to forego those benef‌its (Delmonico et al., 2002; Sandel, 2012).
Understanding and quantifying the inf‌luence of repugnance on social
decisions is challenging. For example, in the context of kidney donations we
cannot observe a paid-donor regime because payments are illegal. In a series of
recent papers (Elias et al., 2015a, 2015b, 2016a), we used survey experiments
conducted in on-line platforms with U.S. residents to study preferences for
repugnance in morally controversial transactions, with focus on the provision of
payments to kidney donors.
In a f‌irst study (Elias et al., 2015a), we found that providing information on
how a price mechanism can help alleviate the organ shortage signif‌icantly
reduced repugnance toward payments for organs. To further understand the
effect of information, in another study (Elias et al., 2015b) we found no effect of
general information about “market eff‌iciency” on the support for paying organ
donors. This indicates that the results of Elias et al. (2015a) were not due to the
participants’ belief that markets can solve every social problem; rather, morally
controversial economic incentives may be accepted only when they are seen as a
solution to a specif‌ic problem.
In a more recent study (Elias et al., 2016a), we found that although systems
that allow for payments to donors raise higher moral concerns than a system with
no payments, a majority of individuals would be willing to accept a more
repugnant system provided that it produced a suff‌iciently large additional
number of transplants.
From a normative standpoint, there is disagreement about what criteria
should shape public policy and regulations and whether the preferences of the
public should inf‌luence the design of those policies. For example, Gillespie (2017)
claims that ethics and legality should be the main guide for policy design. In
contrast, Brennan and Jaworski (2015) advance a consequentialist view to favor
490 World Medical & Health Policy, 9:4

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT